The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling (Q42469020)

1 November 2017

title

The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling (English)

1 reference

1 November 2017

Uwe Kirchhefer

1

1 reference

1 November 2017

Diana Wehrmeister

2

1 reference

1 November 2017

Alex V Postma

3

1 reference

1 November 2017

Gottfried Pohlentz

4

1 reference

1 November 2017

Michael Mormann

5

1 reference

1 November 2017

Dana Kucerova

6

1 reference

1 November 2017

Frank U Müller

7

1 reference

1 November 2017

Wilhelm Schmitz

8

1 reference

1 November 2017

Eric Schulze-Bahr

9

1 reference

1 November 2017

Arthur A Wilde

10

1 reference

1 November 2017

Joachim Neumann

11

1 reference

1 November 2017

publication date

17 March 2010

1 reference

Journal of Molecular and Cellular Cardiology

1 November 2017

published in

1 reference

1 November 2017

volume

49

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

95-105

1 reference

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Mass spectrometry of cardiac calsequestrin characterizes microheterogeneity unique to heart and indicative of complex intracellular transit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Head-to-tail oligomerization of calsequestrin: a novel mechanism for heterogeneous distribution of endoplasmic reticulum luminal proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Direct aldosterone action on mouse cardiomyocytes detected with atomic force microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Structure elucidation of glycoproteins by direct nanoESI MS and MS/MS analysis of proteolytic glycopeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Purification, primary structure, and immunological characterization of the 26-kDa calsequestrin binding protein (junctin) from cardiac junctional sarcoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Intracellular functions of N-linked glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Different endoplasmic reticulum trafficking and processing pathways for calsequestrin (CSQ) and epitope-tagged CSQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Oligomerization is an intrinsic property of calsequestrin in normal and transformed skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Polymerization of calsequestrin. Implications for Ca2+ regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Defective glycosylation of calsequestrin in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Targeting of calsequestrin to the sarcoplasmic reticulum of skeletal muscle upon deletion of its glycosylation site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Subcellular [Ca2+]i gradients during excitation-contraction coupling in newborn rabbit ventricular myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Development of excitation-contraction coupling in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

Changes in the calcium current of rat heart ventricular myocytes during development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.03.006

10.1016/J.YJMCC.2010.03.006

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference